Esaote yesterday announced it was acquired by a consortium of Chinese investors composed of several major companies in the medical field and investment funds.
Genoa, Italy-based Esaote produces medical devices with a focus on ultrasound, dedicated magnetic resonance imaging and diagnostic management software.
The acquiring consortium includes Chinese medical equipment maker Wandong, private equity fund Yufeng Capital, Chinese free trade zone fund Shanghai FTZ Fund, investment group Tianyi, Chinese home medical equipment maker holding company Yuyue and OEM manufacturer Kangda.
Esaote said that with the acquisition, it will accelerate development plans with a focus on growth projects in China, though the company will continue to operate as an independent international company with headquarters in Italy and R&D facilities in Italy and the Netherlands, according to a press release.
Last October, Esaote announced the launch of its MyLab 9 platform.
This year’s DeviceTalks Minnesota features four tracks packed with expertly curated content created by the industry for the industry.
ECO-SYSTEM TRACK: focuses on issues impacting medtech companies across Minnesota and beyond. TECHNOLOGY TRACK: drills down on the hottest new tech that is changing medtech. REGULATORY 201 and CLINCAL 201 TRACKS: Hosted by Medical Alley and focuses on the most important trends in regulatory and clinical development.
Take a look at our full agenda.
Use the code "TRACKS" to save 15% on the cost of registration.